Blair Childs, Senior Vice President, Public Affairs
Premier is pleased to see the Administration reinvigorating the discussion around drug pricing and increased competition. We have been a long-time advocate for boosting competition in the drug marketplace to lower prices and bring the greatest value to our members and the communities they serve. The COVID-19 pandemic only intensifies the need to revive this debate and to use competitive forces to make life-saving treatments more affordable to Americans.
Premier is committed to addressing the rising cost of drugs and looks forward to working collaboratively with the Administration, Congress, and external stakeholders to develop market-based solutions that are attainable, practical, and sustainable.
About Premier, Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 175,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.